Teladoc Health (NYSE:TDOC) Given “Hold” Rating at Needham & Company LLC

Teladoc Health (NYSE:TDOC)‘s stock had its “hold” rating restated by investment analysts at Needham & Company LLC in a report released on Thursday, Benzinga reports.

Several other equities analysts also recently issued reports on TDOC. Citigroup cut their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a report on Monday, August 3rd. Bank of America upped their target price on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research report on Tuesday, July 7th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Teladoc Health in a research note on Wednesday, August 19th. Finally, Canaccord Genuity Group lowered their price target on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Five equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $7.54.

Teladoc Health Price Performance

TDOC stock opened at $6.87 on Thursday. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $9.89. The firm’s 50-day moving average is $6.15 and its 200 day moving average is $6.46. The company has a market capitalization of $1.25 billion, a PE ratio of -6.94 and a beta of 2.14.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 28th. The health services provider reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.07. The firm had revenue of $605.10 million during the quarter, compared to the consensus estimate of $588.14 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%. The firm’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the previous year, the company posted ($0.28) earnings per share. Sell-side analysts forecast that Teladoc Health will post -0.92 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, CEO Charles III sold 17,805 shares of Teladoc Health stock in a transaction on Friday, September 11th. The shares were sold at an average price of $6.10, for a total transaction of $108,610.50. Following the sale, the chief executive officer owned 465,535 shares of the company’s stock, valued at $2,839,763.50. The trade was a 3.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.70% of the company’s stock.

Institutional Trading of Teladoc Health

Several large investors have recently bought and sold shares of TDOC. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Teladoc Health in the 3rd quarter valued at $60,000. Vise Technologies Inc. raised its stake in shares of Teladoc Health by 26.5% in the third quarter. Vise Technologies Inc. now owns 22,035 shares of the health services provider’s stock valued at $128,000 after acquiring an additional 4,614 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al raised its position in Teladoc Health by 9.5% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 186,825 shares of the health services provider’s stock valued at $1,084,000 after purchasing an additional 16,200 shares in the last quarter. Partners Wealth Management LLC acquired a new position in shares of Teladoc Health during the third quarter worth about $58,000. Finally, Oppenheimer & Co. Inc. increased its stake in shares of Teladoc Health by 11.5% during the third quarter. Oppenheimer & Co. Inc. now owns 206,625 shares of the health services provider’s stock worth $1,198,000 after buying an additional 21,334 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Key Teladoc Health News

Here are the key news stories impacting Teladoc Health this week:

• Positive Sentiment: Teladoc reported third-quarter revenue of $605.1 million, exceeding analyst expectations of approximately $588 million. Its adjusted loss of $0.15 per share was also narrower than the expected $0.23 loss, producing earnings and revenue surprises of roughly 35% and 3%, respectively. Teladoc Reports Q3 Loss, Beats Revenue Estimates
• Positive Sentiment: The results showed year-over-year improvement in the loss, with the quarterly loss per share improving from $0.21–$0.28 a year earlier to $0.15. BetterHelp insurance revenue reached $32 million, providing a potential growth avenue for the struggling mental-health business. Teladoc: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: From a technical perspective, TDOC shares crossed above their 200-day moving average, a development that can attract momentum-oriented investors and signal improving market sentiment after a prolonged decline. Teladoc Shares Cross Above 200-Day Moving Average
• Neutral Sentiment: Management forecast fourth-quarter revenue of $569 million to $615 million, or approximately $592 million at the midpoint. The range provides visibility into the near-term outlook, although the midpoint is slightly below consensus expectations. Teladoc Expects Q4 Revenue Range
• Negative Sentiment: Third-quarter revenue declined 3.4% year over year, showing that Teladoc remains in a low-growth environment despite beating estimates. The company also continued to report a net loss and negative profitability metrics. Teladoc Third-Quarter Earnings Results
• Negative Sentiment: The fourth-quarter revenue outlook remains subdued, reinforcing concerns that BetterHelp and the broader virtual-care business may need more time to return to sustained growth. Teladoc Q3 2026 Earnings Call Transcript

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services and technology designed to connect patients with medical professionals remotely. Through its digital platforms, the company supports a range of healthcare needs, including general medical consultations, mental health services, specialty care, and ongoing management of chronic conditions.

Its offerings include telehealth visits with physicians and other licensed providers, behavioral health services through BetterHelp, and chronic care programs that use digital tools and clinical support to help people manage conditions such as diabetes and hypertension.